CRL stock

Charles River Laboratories (CRL) financials · rev $4.02B

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Charles River Laboratories (CRL) rev $4.02B.

Cached annual income statement
LineFY2025FY2024
Revenue$4.02B$4.05B
Operating Income$25.2M$227.3M
Net Income-$144.3M$22.2M
EPS (Diluted)-$2.91$0.20
Cached annual balance sheet
LineFY2025FY2024
Total Assets$7.14B$7.53B
Current Assets$1.45B$1.40B
Cash & Equivalents$213.8M$194.6M
Inventory$299.1M$278.5M
PP&E$1.66B$1.60B
Total Liabilities$3.92B$4.02B
Current Liabilities$1.12B$994.1M
Short-term Debt$166.0K$155.0K
Total Debt$2.14B$2.24B
Shareholders' Equity$3.16B$3.46B
Retained Earnings$1.39B$1.81B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$737.6M$734.6M
CapEx$219.2M$233.0M
Investing Cash Flow-$209.3M-$245.1M
Financing Cash Flow-$536.7M-$550.9M
Net Change in Cash$10.4M-$78.9M
Free Cash Flow$518.5M$501.6M
These statements as JSON? API free 100/day

FAQ

What is CRL P/E and revenue?

Charles River Laboratories (CRL) rev $4.02B.

What is CRL revenue?

Charles River Laboratories last cached revenue is $4.02B (FY2025).

Is CRL profitable?

Charles River Laboratories last cached net income is -$144.3M (FY2025).

What are CRL total assets?

Charles River Laboratories last cached total assets are $7.14B (FY2025).

What is CRL free cash flow?

Charles River Laboratories last cached free cash flow is $518.5M (FY2025).

Not investment advice. Cached statements, not a live tape.